This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Invitae Corporation, Laboratory Corporation of America Holdings, Leland Stanford Junior University. Active years: 2021-2025.
Location History:
- Stanford, CA (US) (2021)
- Menlo Park, CA (US) (2022 - 2023)
Company Filing History:
2 out of 17 
2 out of 125 
1 out of 5,489 
Years Active: 2021-2025
Title: Innovations of Alexandre Colavin
Introduction
Alexandre Colavin is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of genetic and genomic testing through his innovative patents. With a total of 5 patents, Colavin's work focuses on enhancing the understanding of molecular variants and their implications in health.
Latest Patents
Colavin's latest patents include groundbreaking technologies aimed at improving variant pathogenicity estimation. One of his notable inventions is a method for population frequency modeling for quantitative variant pathogenicity estimation. This technology utilizes a logistic regression model applied to population data for specific genes. The model incorporates features that quantify the predictive value of allele frequency, allowing for more accurate variant classification predictions.
Another significant patent is the development of a molecular evidence platform for the auditable and continuous optimization of variant interpretation. This system enhances the determination of the phenotypic impact of molecular variants by regularly updating and auditing the best-performing evidence models across various evidence classes. These innovations reflect Colavin's commitment to advancing genetic research and improving patient outcomes.
Career Highlights
Throughout his career, Alexandre Colavin has worked with prominent companies in the biotechnology sector. He has been associated with Invitae Corporation and Laboratory Corporation of America Holdings, where he has contributed to the development of innovative solutions in genetic testing. His expertise in the field has positioned him as a valuable asset in the industry.
Collaborations
Colavin has collaborated with esteemed colleagues, including Carlos L. Araya and Jason A. Reuter. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in genetic research.
Conclusion
Alexandre Colavin's contributions to the field of genetic and genomic testing through his patents demonstrate his innovative spirit and dedication to improving healthcare. His work continues to influence the understanding of molecular variants and their impact on human health.